Antibacterial action of bile acids against Helicobacter pylori and changes in its ultrastructural morphology:: effect of unconjugated dihydroxy bile acid

被引:47
作者
Itoh, M [1 ]
Wada, K [1 ]
Tan, S [1 ]
Kitano, Y [1 ]
Kai, J [1 ]
Makino, I [1 ]
机构
[1] Asahikawa Med Coll, Dept Internal Med 2, Asahikawa, Hokkaido 0788510, Japan
关键词
bile acid; Heliocobacter pylori; minimum inhibitory concentration; scanning electron microscopy;
D O I
10.1007/s005350050374
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although it has been shown that bile acids possess antibacterial activity against Helicobacter pylori, few reports on their activity have been published. We determined the minimum inhibitory concentration at 72h of various unconjugated and conjugated bile acids against laboratory standard strains and clinical isolates of H. pylori, and studied morphologic changes of H. pylori under the scanning electron microscope during treatment with deoxycholic acid and ursodeoxycholic acid at the minimum inhibitory concentrations for 24h. We found that only the unconjugated form of dihydroxy bile acid has antibacterial activity. The minimum inhibitory concentration of deoxycholic acid is 200-400 mu g/ml, that of chenodeoxycholic acid is similar to that of deoxycholic acid, and that of ursodeoxycholic acid is 400-800 mu g/ml. The morphology of H. pylori changed from its primary rodlike shape to a spherical shape with blebs on the cell surface, and was further degraded to an irregularly condensed mass, following an increase in bile acid. This morphologic change in H. pylori was different from the change to a spherical shape caused by amoxicillin. On the basis of these results, it seems that unconjugated dihydroxy bile acid might be a candidate drug for eradication of H. pylori, but further investigations of the clinical usefulness of bile acid for this purpose should be done.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 17 条
[1]   BACTERICIDAL AND MORPHOLOGICAL EFFECTS OF AMOXICILLIN ON HELICOBACTER-PYLORI [J].
BERRY, V ;
JENNINGS, K ;
WOODNUTT, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) :1859-1861
[2]  
BLINEK J, 1996, SCHWEIZ MED WOCHENSC, V126, P445
[3]  
BODE G, 1992, MED KLIN, V87, P179
[4]  
FLOCH MH, 1971, GASTROENTEROLOGY, V61, P228
[5]   TREATMENT OF PEPTIC-ULCERS CAUSED BY HELICOBACTER-PYLORI [J].
GRAHAM, DY .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (05) :349-350
[6]  
GRAHAM DY, 1989, AM J GASTROENTEROL, V84, P233
[7]   SENSITIVITY OF HELICOBACTER-PYLORI TO DIFFERENT BILE-SALTS [J].
HANNINEN, ML .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (06) :515-518
[8]  
ISHII E, 1990, RINSHO SHOKAKI NAIKA, V5, P1225
[9]   LANSOPRAZOLE, A NOVEL BENZIMIDAZOLE PROTON PUMP INHIBITOR, AND ITS RELATED-COMPOUNDS HAVE SELECTIVE ACTIVITY AGAINST HELICOBACTER-PYLORI [J].
IWAHI, T ;
SATOH, H ;
NAKAO, M ;
IWASAKI, T ;
YAMAZAKI, T ;
KUBO, K ;
TAMURA, T ;
IMADA, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) :490-496
[10]  
*JAP SOC CHEM, 1981, CHEMOTHERAPY, V29, P76